Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00323336 · ClinicalTrials.gov registry record

Markers of Bone Turnover in Saliva and How This Compares to Urine and Blood

A clinical trial, sponsored by Mayo Clinic.

Completed
Registry status
100
Enrollment target

NCT00323336: Completed study, sponsored by Mayo Clinic.

NCT00323336 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00323336 has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
100 participants
Enrollment target

Study Summary

Study is being done to determine if it is possible to use saliva to measure bone specific proteins and predict bone turnover which could be used in the treatment of osteoporosis.

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2006-05
Est. Completion 2007-11
Mayo Clinic

2,844 total trials

What the finished NCT00323336 record still lists

NCT00323336 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00323336 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00323336 about?

NCT00323336 is a clinical study titled "Markers of Bone Turnover in Saliva and How This Compares to Urine and Blood". Study is being done to determine if it is possible to use saliva to measure bone specific proteins and predict bone turnover which could be used in the treatment of osteoporosis.

What is the current status of trial NCT00323336?

This trial is currently completed. The enrollment target is 100 participants. The study started on 2006-05. Estimated completion is 2007-11.

Who is sponsoring clinical trial NCT00323336?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00323336, the US trial registry maintained by the National Library of Medicine. NCT00323336 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.